
The Unseen Struggles Behind Quantum-Si’s Proteomic Promise
Quantum-Si’s Platinum® Pro device democratizes next-gen protein sequencing, unlocking potential insights into diseases like cancer and Alzheimer’s. Despite technological advancements, Quantum-Si faces financial challenges, with shares down 5% and net losses reaching $101.01 million recently. External economic factors, such as tariffs, influence